Lijek Pharmaceuticals Private Limited - Company Profile

It is a chemicals private limited company based in Noida, Uttar Pradesh, India, established in 2016.
2016 Noida, Uttar Pradesh, India Active
Last Updated:
Access Report
About Lijek Pharmaceuticals Private Limited

Lijek Pharmaceuticals Private Limited, a active private limited company, was established on 13 January 2016 in Noida, Uttar Pradesh, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24233UP2016PTC075711. Registered under ROC Roc Uttar Pradesh Ii. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.

It upholds a compliant status. Its leadership includes Bashishth Kumar (Director), Ashish Kumar Jha (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at D-107, Hindon Vihar Barola, Noida, Uttar Pradesh, 201301.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24233UP2016PTC075711

  • Registration Number

    075711

  • Incorporation Date

    13 January 2016

  • Authorized Capital

    ₹0.10 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Uttar Pradesh Ii

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.10 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 1 Month
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** -90.19%
  • Profit Growth **** 21.15%
  • Ebitda **** 80.97%
  • Net Worth -54.50%
  • Total Assets -95.45%
Company report

Lijek Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Lijek Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Lijek Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Bashishth Kumar Director 13 Jan 2016 Current
Ashish Kumar Jha Director 13 Jan 2016 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Lijek Pharmaceuticals.

Lijek Pharmaceuticals Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 90.19% decrease. The company also saw a substantial improvement in profitability, with a 21.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 54.5%.

Lijek Pharmaceuticals revenue growth over time
Lijek Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -90.19%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -95.45%
*******
*******
*******
*******
Profit or Loss
*******
 21.15%
*******
*******
*******
*******
Net Worth
*******
 -54.50%
*******
*******
*******
*******
EBITDA
*******
 80.97%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Lijek Pharmaceuticals?

Unlock access to Lijek Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Lijek Pharmaceuticals?

Unlock and access historical data on people associated with Lijek Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Lijek Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lijek Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Lijek Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    Lijek Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Lijek Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttar Pradesh Ii. was documented.

  • Director Appointment

    Progress on Bashishth Kumar was appointed as a Director was appointed as a Director on 13 Jan 2016 & has been associated with this company since 10 years 1 month . was documented.

  • Director Appointment

    Ashish Kumar Jha was appointed as a Director was appointed as a Director on 13 Jan 2016 & has been associated with this company since 10 years 1 month . was recorded as a recent event.

  • Company Incorporation

    Lijek Pharmaceuticals Private Limited was registered on 13 Jan 2016 with Roc Uttar Pradesh Ii & aged 10 years 1 month as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Lijek Pharmaceuticals Private Limited?

The CIN of Lijek Pharmaceuticals Private Limited is U24233UP2016PTC075711.

Where is Lijek Pharmaceuticals Private Limited headquartered?

Lijek Pharmaceuticals Private Limited is headquartered at D-107, Hindon Vihar Barola, Noida, Uttar Pradesh, 201301.

When was Lijek Pharmaceuticals Private Limited incorporated?

Lijek Pharmaceuticals Private Limited was incorporated on 13 January 2016.

Who are the current directors of Lijek Pharmaceuticals Private Limited?

The current directors of Lijek Pharmaceuticals Private Limited are

What is the primary industry of Lijek Pharmaceuticals Private Limited?

The primary industry of Lijek Pharmaceuticals Private Limited is Chemicals.

Is Lijek Pharmaceuticals Private Limited a listed company?

Lijek Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Lijek Pharmaceuticals Private Limited?

The authorized capital of Lijek Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.

What is the compliance status of Lijek Pharmaceuticals Private Limited?

The compliance status of Lijek Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available